VeriMomIst zinc palmitoyl nonapeptide-14 in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
Pregnancy-safe products containing zinc palmitoyl nonapeptide-14
Related ingredients
Frequently asked questions
- Ist zinc palmitoyl nonapeptide-14 in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
- Ist zinc palmitoyl nonapeptide-14 während des Stillens sicher?
- No evidence of reproductive or lactation-specific hazards from SCCS/CIR/ECHA or peer-reviewed literature for this ingredient. Dermal absorption is expected to be negligible for a large, palmitoylated peptide; therefore systemic exposure sufficient to reach breastmilk is not supported by available regulatory sources (no ECHA harmonised hazard, no CIR or SCCS contraindication).
- Ist zinc palmitoyl nonapeptide-14 sicher für Babyhaut?
- No data indicating intrinsic developmental or reproductive hazard in infants. Mechanistic data are absent. Although adult dermal absorption is expected to be negligible, infant skin has higher surface-area-to-weight and an immature barrier; per the scoring guidance, exposure score is increased by +1 relative to adult (from 0 to 1) in the absence of evidence of complete non-absorbability. No infant-specific adverse data were found in the searched regulatory sources.
- Wie bewertet VeriMom zinc palmitoyl nonapeptide-14?
- VeriMom bewertet zinc palmitoyl nonapeptide-14 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu zinc palmitoyl nonapeptide-14?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu zinc palmitoyl nonapeptide-14 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.